HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of a histologic classification of mouse liver tumors based on pyruvate kinase isozymes and status of host lipids.

Abstract
The histologic classification of mouse liver tumors, i.e., hepatic nodules type 1 and type 2 and hepatocellular carcinomas, was evaluated by a comparison of several biologic and biochemical markers that have been shown to be useful for the grading of tumor malignancy. The liver tumors were induced by N,N'-2,7-fluorenylenebisacetamide (CAS: 304-28-9; N,N'-fluoren-2,7-ylenebisacetamide) administration to male CD-1 mice. The ability to induce L-type pyruvate kinase activity in response to a high-carbohydrate diet disappeared in almost all the liver tumors. However, fairly good correlations were observed between the histologic classification and the relative weights of liver and intraperitoneal fat pads, between the histologic classification and the level of serum total cholesterol, and between the histologic classification and the K-type pyruvate kinase activity. The results suggest that the present histologic classification reflects the degree of tumor malignancy, and therefore, it would be useful for the classification of mouse liver tumors.
AuthorsS Yanagi, H Tsuda, M Sakamoto, Y Ninomiya, N Ito
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 73 Issue 6 Pg. 1311-7 (Dec 1984) ISSN: 0027-8874 [Print] United States
PMID6595442 (Publication Type: Journal Article)
Chemical References
  • Dietary Carbohydrates
  • Dietary Fats
  • Fatty Acids, Nonesterified
  • Isoenzymes
  • Cholesterol
  • Pyruvate Kinase
Topics
  • Animals
  • Cholesterol (blood)
  • Dietary Carbohydrates
  • Dietary Fats
  • Enzyme Induction
  • Fatty Acids, Nonesterified (blood)
  • Isoenzymes (biosynthesis)
  • Liver (enzymology)
  • Liver Neoplasms, Experimental (blood, enzymology, pathology)
  • Male
  • Mice
  • Pyruvate Kinase (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: